Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeraphim Space Regulatory News (SSIT)

Share Price Information for Seraphim Space (SSIT)

Share Price is delayed by 15 minutes
Get Live Data
193.00    0.00 (0.00%)
Bid:
192.20
Ask:
192.40
Spread: 0.20 (0.104%)
Market Cap: £457.79m
SSIT Live PriceLast checked at - London Stock Exchange

Intraday Seraphim Space Share Chart

Additional Non-Executive Director Appointment

8 Dec 2021 07:00

RNS Number : 8982U
Seraphim Space Investment Trust PLC
08 December 2021
 

SERAPHIM SPACE INVESTMENT TRUST PLC

 

("Seraphim Space" or "the Company")

 

 

Additional Non-Executive Director Appointment 

The Board of Seraphim Space Investment Trust plc (LSE: SSIT), the world's first listed SpaceTech fund, is delighted to announce the appointment of Angela Lane as a fourth Non-Executive Director with effect from 1 January 2022. She will also be a member of the Audit, Management Engagement and Remuneration and Nomination Committees and, with effect from 30 June 2022, will succeed Christina McComb as Chair of the Audit Committee.

 

Angela has decades of experience working with private equity owned companies, investment trusts and as the Chair of audit and remuneration committees. She began her career at the venture capital firm 3i and became a partner of 3i's Growth Capital business, overseeing the UK Growth Capital portfolio. Subsequently, she has held a number of positions as Chair of private equity-backed businesses.

 

Angela is currently a Non-Executive Director of BlackRock Throgmorton Investment Trust plc as well as Pacific Horizon Investment Trust plc and Dunedin Enterprise Investment Trust plc, where she also Chairs the Audit Committee.

 

Will Whitehorn, Chair of Seraphim Space Investment Trust plc, commented: "We are delighted to welcome Angela, an experienced Investment Trust Board member, as a member of our Board and Chair-designate of our Audit Committee." 

 

Angela Lane does not currently hold any shares in the Company.

This notification is made pursuant to Listing Rule 9.6.11R.

 

Media Enquiries

Seraphim Space (Manager) LLP (via SEC Newgate)Mark Boggett, CEO / James Bruegger, CIO / Rob Desborough

 

SEC Newgate (Communications advisers) seraphim@secnewgate.co.uk Emma Kane / Clotilde Gros / Tom Carnegie +44 (0) 3757 6767

 

Deutsche Bank Mark Hankinson / Neil Collingridge / Neil Coleman +44 (0) 20 754 58000 

J.P. Morgan CazenoveWilliam Simmonds / Jérémie Birnbaum / Rupert Budge +44 (0) 20 7742 4000 

Ocorian Administration (UK) Limited seraphimteam@ocorian.com 

Lorna Zimny / Eimear Coleman +44 28 9078 5880

 

 

 

 Notes to Editors

About Seraphim Space Investment Trust

Seraphim Space Investment Trust is the world's first listed fund focused on Space Tech. The Company seeks exposure predominantly to early and growth stage private financed Space Tech businesses that have the potential to dominate globally and that are sector leaders with first mover advantages in areas such as climate, communications, mobility and cyber security.

The Company listed on the Premium Segment of the London Stock Exchange on 14 July 2021, following an oversubscribed IPO raising £178.4 million. It currently has exposure to 19 Space Tech companies and has agreed to acquire investments in a further two companies by 31 December 2021.

Seraphim Space Investment Trust is managed by Seraphim Space (Manager) LLP.

Further information is available at: www.seraphim.vc

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEAFTLDIIL
Date   Source Headline
12th May 20227:00 amRNSQ3 Results
26th Apr 20227:00 amRNSNotice of Results and Capital Markets Day
24th Feb 20222:07 pmRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSInterim Results
18th Feb 202212:23 pmRNSHolding(s) in Company
17th Feb 20223:57 pmRNSHolding(s) in Company
17th Feb 20223:36 pmRNSHolding(s) in Company
11th Feb 20222:15 pmRNSNotice of Results
27th Jan 202211:41 amRNSD-Orbit SPAC Announcement
10th Jan 20225:09 pmRNSReduction of Share Premium Account
4th Jan 20227:00 amRNSTotal Voting Rights
22nd Dec 20215:17 pmRNSHolding(s) in Company
21st Dec 202111:33 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSCompletion of Investments
14th Dec 20219:00 amRNSDirector Declaration
8th Dec 20217:00 amRNSAdditional Non-Executive Director Appointment
6th Dec 20217:00 amRNS$25 million investment in ICEYE Oy
25th Nov 20217:00 amRNS$12.5m investment in Astroscale
19th Nov 20217:00 amRNSQ1 Results
8th Nov 20217:00 amRNS$25m investment in HawkEye 360
2nd Nov 20217:00 amRNSNotice of Results
11th Oct 20211:39 pmRNSHolding(s) in Company
11th Oct 20211:14 pmRNSHolding(s) in Company
11th Oct 20211:11 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSTotal Voting Rights
27th Sep 20217:00 amRNS$25 million investment into Isotropic Systems
21st Sep 20213:52 pmRNSCompletion of Investment in Arqit Quantum Inc.
9th Sep 20217:00 amRNSCompletion of Investment in Spire Global, Inc.
7th Sep 20211:15 pmRNSArqit Limited SPAC Completion
18th Aug 20217:00 amRNSSpire Global SPAC Completion and Transfer
2nd Aug 20217:00 amRNSTotal Voting Rights
28th Jul 202110:22 amRNSHolding(s) in Company
23rd Jul 20213:15 pmRNSDirector/PDMR Shareholding
16th Jul 20212:52 pmRNSInvestment into LeoLabs
14th Jul 20218:00 amRNSAdmission to Trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.